Journal of Surgery Concepts & Practice ›› 2022, Vol. 27 ›› Issue (05): 468-472.doi: 10.16139/j.1007-9610.2022.05.017
• Review • Previous Articles Next Articles
ZHU Siyi, CHEN Xiaosong, SHEN Kunwei()
Received:
2021-04-06
Online:
2022-09-25
Published:
2022-11-10
Contact:
SHEN Kunwei
E-mail:kwshen@medmail.com.cn
CLC Number:
ZHU Siyi, CHEN Xiaosong, SHEN Kunwei. Study on obesity associated with prognosis of early breast cancer and efficacy of adjuvant therapy[J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 468-472.
[1] | World Cancer Research Fund. Body fatness and weight gain and the risk of cancer[EB/OL]. ( 2021-01-21) [2021-05-14]. . |
[2] | Desmedt C, Fornili M, Clatot F, et al. Differential benefit of adjuvant docetaxel-based chemotherapy in patients with early breast cancer according to baseline body mass index[J]. J Clin Oncol, 2020, 38(25):2883-2891. |
[3] | Crozier JA, Moreno-Aspitia A, Ballman KV, et al. Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831[J]. Cancer, 2013, 119(13):2447-2454. |
[4] | Jiralerspong S, Kim ES, Dong W, et al. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients[J]. Ann Oncol, 2013, 24(10):2506-2514. |
[5] | Copson ER, Cutress RI, Maishman T, et al. Obesity and the outcome of young breast cancer patients in the UK: the POSH study[J]. Ann Oncol, 2015, 26(1):101-112. |
[6] | Widschwendter P, Friedl TW, Schwentner L, et al. The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial[J]. Breast Cancer Res, 2015, 17(1):129. |
[7] | Pajares B, Pollán M, Martín M, et al. Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis[J]. Breast Cancer Res, 2013, 15(6):R105. |
[8] | Sparano JA, Wang M, Zhao F, et al. Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer[J]. Cancer, 2012, 118(23):5937-5946. |
[9] | Ewertz M, Gray KP, Regan MM, et al. Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial[J]. J Clin Oncol, 2012, 30(32):3967-3975. |
[10] | Wang J, Cai Y, Yu F, et al. Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies[J]. BMC Cancer, 2020, 20(1):601. |
[11] | Daling JR, Malone KE, Doody DR, et al. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma[J]. Cancer, 2001, 92(4):720-729. |
[12] | Torres-de la Roche LA, Steljes I, Janni W, et al. The association between obesity and premenopausal breast cancer according to intrinsic subtypes-a systematic review[J]. Geburtshilfe Frauenheilkd, 2020, 80(6):601-610. |
[13] | Kwan ML, Kroenke CH, Sweeney C, et al. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression[J]. BMC Cancer, 2015, 15:278. |
[14] | Bergom C, Kelly T, Bedi M, et al. Association of locoregional control with high body mass index in women undergoing breast conservation therapy for early-stage breast cancer[J]. Int J Radiat Oncol Biol Phys, 2016, 96(1):65-71. |
[15] | Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults[J]. N Engl J Med, 2003, 348(17):1625-1638. |
[16] | Chan DSM, Vieira AR, Aune D, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies[J]. Ann Oncol, 2014, 25(10):1901-1914. |
[17] | Jeon YW, Kang SH, Park MH, et al. Relationship between body mass index and the expression of hormone receptors or human epidermal growth factor receptor 2 with respect to breast cancer survival[J]. BMC Cancer, 2015, 15:865. |
[18] | Nechuta S, Chen WY, Cai H, et al. A pooled analysis of post-diagnosis lifestyle factors in association with late estrogen-receptor-positive breast cancer prognosis[J]. Int J Cancer, 2016, 138(9):2088-2097. |
[19] | Wolters R, Schwentner L, Regierer A, et al. Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle[J]. Breast Cancer Res Treat, 2012, 131(3):925-931. |
[20] | Cespedes Feliciano EM, Kwan ML, Kushi LH, et al. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer[J]. Cancer, 2017, 123(13):2535-2542. |
[21] | Ligibel JA, Cirrincione CT, Liu M, et al. Body mass index, PAM50 subtype, and outcomes in node-positive breast cancer: CALGB 9741(Alliance)[J]. J Natl Cancer Inst, 2015, 107(9):djv179. |
[22] | Picon-Ruiz M, Morata-Tarifa C, Valle-Goffin JJ, et al. Obesity and adverse breast cancer risk and outcome: mechanistic insights and strategies for intervention[J]. CA Cancer J Clin, 2017, 67(5):378-397. |
[23] | Ballinger TJ, Jiang G, Kassem N, et al. Impact of body mass index on presence of ctDNA and disease recurrence after neoadjuvant chemotherapy for triple-negative breast cancer: analysis from BRE12-158[J]. Clin Cancer Res, 2021, 27(4):1195-1199. |
[24] | Lohmann AE, Soldera SV, Pimentel I, et al. Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis[J]. J Natl Cancer Inst, 2021, 113(11):1465-1475. |
[25] | Choi Y, Park SK, Ahn KJ, et al. Being overweight or obese increases the risk of progression in triple-negative breast cancer after surgical resection[J]. J Korean Med Sci, 2016, 31(6):886-891. |
[26] | Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene[J]. Science, 1987, 235(4785):177-182. |
[27] | Mazzarella L, Disalvatore D, Bagnardi V, et al. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients[J]. Eur J Cancer, 2013, 49(17):3588-3597. |
[28] | Cantini L, Pistelli M, Merloni F, et al. Body mass index and hormone receptor status influence recurrence risk in HER2-positive early breast cancer patients[J]. Clin Breast Cancer, 2020, 20(1):e89-e98. |
[29] | Martel S, Lambertini M, Agbor-Tarh D, et al. Body mass index and weight change in patients with HER2-positive early breast cancer: exploratory analysis of the ALTTO BIG 2-06 Trial[J]. J Natl Compr Canc Netw, 2021, 19(2):181-189. |
[30] | Cecchini RS, Swain SM, Costantino JP, et al. Body mass index at diagnosis and breast cancer survival prognosis in clinical trial populations from NRG oncology/NSABP B-30, B-31, B-34, and B-38[J]. Cancer Epidemiol Biomar-kers Prev, 2016, 25(1):51-59. |
[31] | Yerushalmi R, Dong B, Chapman JW, et al. Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials[J]. Ann Oncol, 2017, 28(7):1560-1568. |
[32] | Tong Y, Wu J, Huang O, et al. IGF-1 interacted with obesity in prognosis prediction in HER2-positive breast cancer patients[J]. Front Oncol, 2020, 10:550. |
[33] | Jiralerspong S, Goodwin PJ. Obesity and breast cancer prognosis: evidence, challenges, and opportunities[J]. J Clin Oncol, 2016, 34(35):4203-4216. |
[34] | Berclaz G, Li S, Price KN, et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience[J]. Ann Oncol, 2004, 15(6):875-884. |
[35] | de Azambuja E, McCaskill-Stevens W, Francis P, et al. The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial[J]. Breast Cancer Res Treat, 2010, 119(1):145-153. |
[36] | Sparreboom A, Wolff AC, Mathijssen RH, et al. Evaluation of alternate size descriptors for dose calculation of anticancer drugs in the obese[J]. J Clin Oncol, 2007, 25(30):4707-4713. |
[37] | Pfeiler G, Königsberg R, Fesl C, et al. Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial[J]. J Clin Oncol, 2011, 29(19):2653-2659. |
[38] | Sestak I, Distler W, Forbes JF, et al. Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial[J]. J Clin Oncol, 2010, 28(21):3411-3415. |
[39] | Seynaeve C, Hille E, Hasenburg A, et al. The impact of body mass index(BMI) on the efficacy of adjuvant endocrine therapy in postmenopausal hormone sensitive breast cancer(BC) patients[J]. Cancer Res, 2010, 70( < W>24 Suppl):Abstract nr S2-3. |
[40] | Sendur MA, Aksoy S, Zengin N, et al. Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index[J]. Br J Cancer, 2012, 107(11):1815-1819. |
[1] | LI Hui, YIN Yu, LI Chunxiao, et al. Research progress on rehabilitation effect of respiratory training on breast cancer-related lymphedema [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(4): 430-. |
[2] | ZHU Danli, BAO Wanting, WEI Hao, et al. Advances in breast reconstruction after breast cancer surgery [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(2): 201-. |
[3] | ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong. Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 371-377. |
[4] | YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382. |
[5] | HUANG Xianjue, YAO Qiyuan. Minimally invasive surgery facilitates surgical treatment of obesity and metabolic diseases [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 215-219. |
[6] | DONG Jun, CUI Fengming, LIU Jun. Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 254-259. |
[7] | ZHANG Yin, SHEN Honghua, XU Yiming, REN Lei, LI jun, WU Shunjun, LING Xiaonan. Effect of sarcopenia combined with abdominal obesity on muscle strength and physical function in hospitalized elderly [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 76-82. |
[8] | XING Ying, CHENG Shi. Neoadjuvant therapy for gallbladder cancer: current status and challenge [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 110-114. |
[9] | GAO Weiqi, ZHANG Xu, WANG Zheng, ZHU Yifei, HUANG Jiahui, HONG Jin, ZHU Siji, CHEN Xiaosong, HUANG Ou, HE Jianrong, CHEN Weiguo, LI Yafen, SHEN Kunwei, XU Hua, WU Jiayi. Safety analysis of immediate breast reconstruction with deep inferior epigastric perforator after neoadjuvant treatment [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 147-151. |
[10] | ZHANG Mengxiao, SUN Shuoshuo, WEI Xiao, ZHANG Shaohong, CHEN Guofang, LIU Chao. Ketogenic diet promotes hepatic lipid accumulation in db/db mice [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 56-63. |
[11] |
ZHANG Xiaoli, LI Zan, SONG Dajiang, et al.
Clinical application of the pedicled lateral thoracic artery perforation flap in breast reconstruction immediately after breast-conserving surgery [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 382-. |
[12] |
SONG Dajiang, LI Zan, ZHANG Yixin.
Surgical strategy of huge chest wall defect reconstruction using pedicled rectus abdominis musculocutaneous flap combined with free deep inferior epigastric artery perforator flap [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 386-. |
[13] |
CHEN Kuo, SONG Dajiang, MU Lan, et al.
Repair of abdominal wall donor site defect of TRAM by freeing the anterior rectus sheath of superior rectus abdominis -- An attempt to make patch with autologous tissue [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 393-. |
[14] | LIU Min (刘 敏), YI Ming (易 鸣), WU Minghu∗ (武明虎), WANG Juan (王 娟), HE Yu (何 宇). Breast Pathological Image Classification Based on VGG16 Feature Concatenation [J]. J Shanghai Jiaotong Univ Sci, 2022, 27(4): 473-484. |
[15] |
YAO Chengcai, CHEN Ming, LIU Changchun, et al.
Application of silicone gel breast prosthesis combined with titanium polypropylene mesh in immediate breast reconstruction for early breast cancer [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(3): 247-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||